In the last trading session, 1.81 million Coherus Biosciences Inc (NASDAQ:CHRS) shares changed hands as the company’s beta touched 0.85. With the company’s per share price at $0.80 changed hands at $0.04 or 5.12% during last session, the market valuation stood at $92.75M. CHRS’s last price was a discount, traded about -203.75% off its 52-week high of $2.43. The share price had its 52-week low at $0.66, which suggests the last value was 17.5% up since then.
Analysts gave the Coherus Biosciences Inc (CHRS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.83. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended CHRS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Coherus Biosciences Inc (NASDAQ:CHRS) trade information
Instantly CHRS was in green as seen at the end of in last trading. With action -21.57%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -42.03%, with the 5-day performance at -21.57% in the red. However, in the 30-day time frame, Coherus Biosciences Inc (NASDAQ:CHRS) is -28.57% down.
The consensus price target for the stock as assigned by Wall Street analysts is 3.52, meaning bulls need an upside of 77.27% from its current market value. According to analyst projections, CHRS’s forecast low is 1.05 with 6 as the target high. To hit the forecast high, the stock’s price needs a -650.0% plunge from its current level, while the stock would need to soar -31.25% for it to hit the projected low.
Coherus Biosciences Inc (CHRS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -27.36%. The 2025 estimates are for Coherus Biosciences Inc earnings to decrease by -611.36%.
Coherus Biosciences Inc (NASDAQ:CHRS)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.2339% or 10.6 million shares worth $18.34 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 3.43 shares estimated at $2.75 million under it, the former controlled 2.96% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.50% of the shares, roughly 2.9 shares worth around $2.32 million.
